Peripheral neuropathy screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Peripheral neuropathy}} {{CMG}}; {{AE}} {{MMJ}} ==Overview== ==Screening== Annual screening for peripheral neuropathy is recommended every year among patients...") |
No edit summary |
||
| Line 1: | Line 1: | ||
* | |||
__NOTOC__ | __NOTOC__ | ||
{{Peripheral neuropathy}} | {{Peripheral neuropathy}} | ||
| Line 5: | Line 6: | ||
==Overview== | ==Overview== | ||
Annual screening for peripheral neuropathy is recommended every year among patients with [[diabetes mellitus]] by: [[Monofilament fishing line|Semmes-Weinstein monofilament examination]], [[Superficial]] [[pain]] [[sensation]] testing, [[Vibration|vbration]] testing by the on-off method and [[vibration]] testing by the timed method. The reported operating characteristics for each [[sensory]] modality can be applied to positive findings on the [[physical examination]] of individual patients to predict the likelihood of [[neuropathy]]. [[Monofilament fishing line|Semmes-Weinstein monofilament examination]] is an appropriate, cheap and easy to use tool for identifying patients at risk of having [[neuropathy]] in primary care setting in patients with [[diabetes mellitus]]. The 1 g [[monofilament]] and total Norfolk quality of life [[diabetic neuropathy]] are effective, low-cost tools for the early detection of [[diabetic]] peripheral neuropathy. The 128 Hz tuning fork and 10 g monofilament may assist [[diabetic]] peripheral neuropathy screening as a tandem, but not primary, early [[diabetic]] peripheral neuropathy detection screening tools. | |||
==Screening== | ==Screening== | ||
* Annual screening for peripheral neuropathy is recommended every year among patients with [[diabetes mellitus]] by:<ref name="pmid11213874">{{cite journal| author=Perkins BA, Olaleye D, Zinman B, Bril V| title=Simple screening tests for peripheral neuropathy in the diabetes clinic. | journal=Diabetes Care | year= 2001 | volume= 24 | issue= 2 | pages= 250-6 | pmid=11213874 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11213874 }} </ref><ref name="pmid26435536">{{cite journal| author=Ogbera AO, Adeleye O, Solagberu B, Azenabor A| title=Screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in a Nigerian University Teaching Hospital. | journal=BMC Res Notes | year= 2015 | volume= 8 | issue= | pages= 533 | pmid=26435536 | doi=10.1186/s13104-015-1423-2 | pmc=4592746 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26435536 }} </ref> | |||
**[[Monofilament fishing line|Semmes-Weinstein monofilament examination]] | |||
**[[Superficial]] [[pain]] [[sensation]] testing | |||
**[[Vibration]] testing by the on-off method | |||
**[[Vibration]] testing by the timed method | |||
* The reported operating characteristics for each [[sensory]] modality can be applied to positive findings on the [[physical examination]] of individual patients to predict the likelihood of [[neuropathy]].<ref name="pmid11213874">{{cite journal| author=Perkins BA, Olaleye D, Zinman B, Bril V| title=Simple screening tests for peripheral neuropathy in the diabetes clinic. | journal=Diabetes Care | year= 2001 | volume= 24 | issue= 2 | pages= 250-6 | pmid=11213874 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11213874 }} </ref> | |||
* [[Monofilament fishing line|Semmes-Weinstein monofilament examination]] is an appropriate, cheap and easy to use tool for identifying patients at risk of having [[neuropathy]] in primary care setting in patients with [[diabetes mellitus]].<ref name="pmid23580893">{{cite journal| author=Al-Geffari M| title=Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in Primary Health Care setting. | journal=Int J Health Sci (Qassim) | year= 2012 | volume= 6 | issue= 2 | pages= 127-34 | pmid=23580893 | doi= | pmc=3616942 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23580893 }} </ref><ref name="pmid26435536">{{cite journal| author=Ogbera AO, Adeleye O, Solagberu B, Azenabor A| title=Screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in a Nigerian University Teaching Hospital. | journal=BMC Res Notes | year= 2015 | volume= 8 | issue= | pages= 533 | pmid=26435536 | doi=10.1186/s13104-015-1423-2 | pmc=4592746 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26435536 }} </ref> | |||
The | * The 1 g [[monofilament]] and total Norfolk quality of life [[diabetic neuropathy]] are effective, low-cost tools for the early detection of [[diabetic]] peripheral neuropathy. The 128 Hz tuning fork and 10 g monofilament may assist [[diabetic]] peripheral neuropathy screening as a tandem, but not primary, early [[diabetic]] peripheral neuropathy detection screening tools.<ref name="pmid29250555">{{cite journal| author=Brown JJ, Pribesh SL, Baskette KG, Vinik AI, Colberg SR| title=A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes. | journal=J Diabetes Res | year= 2017 | volume= 2017 | issue= | pages= 1467213 | pmid=29250555 | doi=10.1155/2017/1467213 | pmc=5698816 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29250555 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 15:45, 22 August 2018
|
Peripheral neuropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Peripheral neuropathy screening On the Web |
|
American Roentgen Ray Society Images of Peripheral neuropathy screening |
|
Risk calculators and risk factors for Peripheral neuropathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Annual screening for peripheral neuropathy is recommended every year among patients with diabetes mellitus by: Semmes-Weinstein monofilament examination, Superficial pain sensation testing, vbration testing by the on-off method and vibration testing by the timed method. The reported operating characteristics for each sensory modality can be applied to positive findings on the physical examination of individual patients to predict the likelihood of neuropathy. Semmes-Weinstein monofilament examination is an appropriate, cheap and easy to use tool for identifying patients at risk of having neuropathy in primary care setting in patients with diabetes mellitus. The 1 g monofilament and total Norfolk quality of life diabetic neuropathy are effective, low-cost tools for the early detection of diabetic peripheral neuropathy. The 128 Hz tuning fork and 10 g monofilament may assist diabetic peripheral neuropathy screening as a tandem, but not primary, early diabetic peripheral neuropathy detection screening tools.
Screening
- Annual screening for peripheral neuropathy is recommended every year among patients with diabetes mellitus by:[1][2]
- Semmes-Weinstein monofilament examination
- Superficial pain sensation testing
- Vibration testing by the on-off method
- Vibration testing by the timed method
- The reported operating characteristics for each sensory modality can be applied to positive findings on the physical examination of individual patients to predict the likelihood of neuropathy.[1]
- Semmes-Weinstein monofilament examination is an appropriate, cheap and easy to use tool for identifying patients at risk of having neuropathy in primary care setting in patients with diabetes mellitus.[3][2]
- The 1 g monofilament and total Norfolk quality of life diabetic neuropathy are effective, low-cost tools for the early detection of diabetic peripheral neuropathy. The 128 Hz tuning fork and 10 g monofilament may assist diabetic peripheral neuropathy screening as a tandem, but not primary, early diabetic peripheral neuropathy detection screening tools.[4]
References
- ↑ 1.0 1.1 Perkins BA, Olaleye D, Zinman B, Bril V (2001). "Simple screening tests for peripheral neuropathy in the diabetes clinic". Diabetes Care. 24 (2): 250–6. PMID 11213874.
- ↑ 2.0 2.1 Ogbera AO, Adeleye O, Solagberu B, Azenabor A (2015). "Screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in a Nigerian University Teaching Hospital". BMC Res Notes. 8: 533. doi:10.1186/s13104-015-1423-2. PMC 4592746. PMID 26435536.
- ↑ Al-Geffari M (2012). "Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in Primary Health Care setting". Int J Health Sci (Qassim). 6 (2): 127–34. PMC 3616942. PMID 23580893.
- ↑ Brown JJ, Pribesh SL, Baskette KG, Vinik AI, Colberg SR (2017). "A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes". J Diabetes Res. 2017: 1467213. doi:10.1155/2017/1467213. PMC 5698816. PMID 29250555.